involved in promoter recognition at the Ϫ10 and Ϫ35 positions (reviewed in reference 5). This conservation of amino acid residues involved in promoter recognition contrasts with the observed variability in the DNA sequences of the putative C. trachomatis promoters.
Recently, Mathews et al. (23) reported an in vitro transcription system which can be used to functionally characterize chlamydial promoters. Using a high-salt extract from C. psittaci and C. trachomatis reticulate bodies (RBs), they were able to show A -dependent transcription of several chlamydial genes, including PCT, hctB, ltuA, and ltuB (6, 14, 23) . Single mutations in the Ϫ10 and Ϫ35 regions of the putative PCT promoter region had no effect on promoter activity (24) . Multiple mutations were required to reduce or eliminate promoter activity. However, the contribution of sequences outside the Ϫ10 and Ϫ35 positions was not examined.
We have developed an improved in vitro transcription system to characterize rRNA P1, the highly transcribed promoter common to both C. trachomatis rRNA operons. We chose to study this promoter because in E. coli, the rRNA promoters are strong promoters that closely resemble the canonical 70 promoter structure. By analogy, the structure of the C. trachomatis rRNA P1 promoter may also resemble the canonical C. trachomatis A promoter structure. In addition, E. coli rrnB P1 contains a third promoter element, the UP element, which serves as a site of interaction for the ␣ subunit of RNAP (30) . The UP element has been shown to increase the level of transcription of E. coli rrnB P1 up to 30-fold, and it is postulated to be involved in the high-level expression of specific genes required for rapid growth.
We have characterized C. trachomatis rRNA P1 by using a stepwise mutational analysis of the putative promoter region. We identified sequences in the approximate Ϫ10 and Ϫ35 regions and in the Ϫ21 to Ϫ30 region that are necessary for promoter activity. Interestingly, partially purified C. trachomatis RNAP and purified E. coli holoenzyme exhibited some differences in promoter specificity.
MATERIALS AND METHODS
Reagents. Products were obtained from the following sources and were used according to the manufacturers' specifications. Restriction enzymes, bacterial alkaline phosphatase, exonuclease III, mung bean nuclease, and T4 DNA ligase were from Gibco BRL (Gaithersburg, Md.); T4 DNA polymerase and T4 polynucleotide kinase were from Boehringer Mannheim Biochemicals (Indianapolis, Ind.); RQ1 DNase and RNasin were from Promega Biotech (Madison, Wis.); 1 min, and polymerization at 72ЊC for 30 s) unless otherwise stated. Purification of C. trachomatis RNAP. The purification method was modified from the heparin-agarose procedure described by Chamberlin et al. (4) . C. trachomatis L2 was grown in 1 liter of L929 cells (a mouse fibroblast cell line) in spinner flasks in RPMI 1640 tissue culture medium with 25 mM N-2-hydroxyethylpiperazine-NЈ-2-ethanesulfonic acid (HEPES), 5% fetal bovine serum (Gibco BRL), vancomycin hydrochloride (60 g/ml), and gentamicin sulfate (10 g/ml). RBs were harvested at 18 to 24 h postinfection by centrifuging the infected L cells at 2,500 ϫ g for 10 min in a Beckman JA 10 rotor at 4ЊC. All subsequent steps were performed at 4ЊC. The pellet was resuspended in 35 ml of phosphate-buffered saline (pH 7.5), and host L929 cells were lysed in a 40-ml Wheaton homogenizer with an A pestle. The lysate was centrifuged at 3,000 rpm for 10 min (Sorvall RT6000B centrifuge with an H-1000B rotor), and the subsequent supernatant fluid was centrifuged at 17,000 ϫ g for 10 min (Beckman JA 20 rotor). The wet weight of the RB-containing pellet was approximately 400 mg. This RB pellet was resuspended in 2 ml of freshly prepared lysis buffer (10 mM Tris-HCl [pH 8.0], 10 mM MgCl 2 , 1 mM EDTA, 7.5% [vol/vol] glycerol, 0.3 mM dithiothreitol [DTT], 1 mM phenylmethylsulfonyl fluoride, 150 g of lysozyme per ml, 10 g of pepstatin A per ml) containing 0.6 M NaCl. Twenty microliters of 10% (vol/vol) Nonidet P-40 (Sigma) was added, and the mix was incubated on ice for 5 min. The RBs were lysed by sonication (Branson Sonifier 450 with microtip; two 10-s cycles at high setting). The lysate was centrifuged at 16,000 ϫ g for 30 min (Eppendorf model 5415C centrifuge), and the supernatant fluid was collected and clarified by two to three additional centrifugations of 15 min each. The clarified supernatant fluid was diluted with 1.4 volumes of buffer I (10 mM Tris-HCl [pH 8.0], 10 mM MgCl 2 , 1 mM EDTA, 7.5% [vol/vol] glycerol, 0.3 mM DTT) to give a final concentration of 0.25 M NaCl. This diluted supernatant fluid was mixed for 1 h with 1 ml of heparin-agarose (type II-S; Sigma) previously equilibrated with buffer I containing 0.25 M NaCl. The heparin-agarose column was packed and washed by gravity flow with 20 ml of buffer I containing 0.25 M NaCl. The column was eluted with buffer I containing 0.6 M NaCl, and 0.5-ml fractions were collected. Fractions were dialyzed against storage buffer (10 mM Tris-HCl [pH 8.0], 10 mM MgCl 2 , 0.1 mM EDTA, 0.1 mM DTT, 100 mM NaCl, 30% [vol/vol] glycerol) and stored at Ϫ70ЊC. Peak fractions were identified by their in vitro transcription activity. Transcription activity was generally recovered in 1 column volume.
Transcription templates. The terminator plasmid pMT175 contains C. trachomatis rRNA P1 and P2 cloned upstream of a T7 terminator (Fig. 1) . The P1 and P2 transcripts are initiated 183 to 185 and 83 to 84 bp, respectively, upstream of the start of the 16S rRNA gene. The two C. trachomatis promoters are located within a 305-bp upstream region on a 550-bp XbaI-SphI fragment which was derived from plasmid pRC66 (12) . This XbaI-SphI fragment was subcloned into pMT171 at the SmaI polylinker site. pMT171 is a derivative of plasmid pTE103 (7) in which approximately 230 bp have been deleted, leaving 66 to 67 bp between the multiple cloning site and the T7 terminator. Transcription from P1 and P2, assuming termination at the T7 terminator, is predicted to produce transcripts 303 to 306 and 203 to 205 nucleotides in length, respectively.
The double G-less cassette plasmid contains two transcription templates cloned into the plasmid pGEM-7Zf(ϩ) (Promega Biotech) in opposite directions and coding for transcripts of 160 and 132 nucleotides (Fig. 1) . The shorter transcript is encoded by a control transcription template inserted into pGEM7Zf(ϩ) at the SmaI site. This control template consists of C. trachomatis rRNA P1 sequences from Ϫ53 to ϩ5 (see Fig. 4 ) cloned immediately upstream of a 127-bp control G-less cassette. The second of the three in vivo transcription initiation sites is a guanosine residue, and this was replaced by an adenosine residue (at ϩ2) to allow for transcription in the absence of GTP. The control G-less cassette was derived from plasmid p(Ϫ47)-(G-)-I (27) by PCR using primer Tx5 and the M13 reverse Ϫ40 primer. This synthetic control template codes for a 132-nucleotide transcript. The test transcription template contains a 155-nucleotide test G-less cassette which was derived from plasmid p(Ϫ47)-(G-)-I (27) by PCR using primers Tx6 and Tx4. It was cloned into pGEM-7Zf(ϩ) at the EcoRI and KpnI sites, in the opposite direction to the control transcription template. This test G-less cassette contains an EcoRV restriction site at its 5Ј end, providing a convenient site into which a test promoter can be cloned. The plasmid containing the control transcription template and a promoterless test G-less cassette is called pMT504. All the G-less cassette transcription templates described in this report were derived from pMT504 by the cloning of a test promoter region into the EcoRI and EcoRV sites of pMT504. In each case, the synthetic test template codes for a 160-nucleotide transcript.
Supercoiled DNA plasmids for use in the in vitro transcription assays were prepared by using a Qiagen Plasmid Midi kit (Qiagen Inc., Chatsworth, Calif.) according to the manufacturer's directions. The DNA sequences of the promoter templates were determined to ascertain that no mutations had occurred during the PCR and cloning steps.
Construction of 5-deletion templates. pMT513 ( Fig. 1 ) contains 305 bp of rRNA P1 upstream sequences (ϩ305 to Ϫ5) which were amplified from plasmid pMT175 (see above) by PCR using primers Tx1 and rRNA-3. The PCR product was digested with EcoRI, phosphorylated, and ligated to the double G-less cassette plasmid pMT504 previously digested with EcoRI and EcoRV. Nested 5Ј deletions of this 305-bp rRNA P1 upstream region were generated from pMT513 (Table 1 ) by using exonuclease III and mung bean nuclease as specified by the manufacturer (Gibco BRL).
Construction of deletion templates. Mutant templates of rRNA P1 containing deletions near the transcription initiation site (Table 1) were generated by PCR from plasmid pMT514, which contains 53 bp of rRNA P1 upstream sequences as the test promoter. For each PCR, the M13 forward Ϫ40 primer was used as the 5Ј PCR primer. The following 3Ј PCR primers were used to generate their respective deletion templates: Tx2 (⌬3, deletion of Ϫ3 to Ϫ1), Tx23 (⌬5, deletion of Ϫ5 to Ϫ1), Tx3 (⌬6, deletion of Ϫ6 to Ϫ1), and Tx24 (⌬7, deletion of Ϫ7 to Ϫ1). Each PCR product was phosphorylated, digested with EcoRI, and ligated to plasmid pMT504 previously digested with EcoRI and EcoRV ( 
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Megaprimer method for generating base substitution mutant templates. An adaptation of the megaprimer method (37) was used to introduce desired mutations into the rRNA P1 upstream sequence. In the first of two PCRs, an oligonucleotide containing the desired mutation was used to generate a mutant template (the megaprimer). The megaprimer was then extended on a DNA template, so as to incorporate convenient restriction sites into the mutant template. In the second PCR, the extended megaprimer was amplified to produce quantities of the mutant template sufficient for cloning.
For each mutant template, a megaprimer was produced by PCR using plasmid pMT513 as the template, the 3Ј primer pGLS3Ј, and the respective 5Ј primer from the following list (with the location of the 5-bp substitution in parentheses): Tx7 (Ϫ50 to Ϫ46), Tx8 (Ϫ45 to Ϫ41), Tx9 (Ϫ40 to Ϫ36), Tx10 (Ϫ35 to Ϫ31), Tx11 (Ϫ30 to Ϫ26), Tx12 (Ϫ25 to Ϫ21), Tx13 (Ϫ20 to Ϫ16), and Tx14 (Ϫ15 to Ϫ11) ( Table 1 ). The megaprimer PCR product was electrophoresed on a 3% low-melting-temperature agarose gel (SeaPlaque), and a gel slice containing the 110-to 145-bp product was excised; 1.5 ml of 10 mM Tris-HCl (pH 8.0)-1 mM EDTA was added, and the gel slice was melted at 65ЊC for 15 min. The melted gel slice was frozen at Ϫ70ЊC for 15 min and thawed at room temperature. Supernatant fluid was collected after centrifugation at 16,000 ϫ g for 5 min (Eppendorf model 5415C centrifuge), and the megaprimer was recovered by ethanol precipitation. Thirty nanograms of megaprimer was extended with T4 DNA polymerase, using 100 ng of heat-denatured linearized plasmid pMT175 as the template in a 10-l reaction volume. In the second PCR, 2 l of the extended megaprimer mix was used as the template with 100 pmol of primers rRNA-4 and pGLS3Ј. Each PCR product was digested with EcoRI and DraI and ligated to plasmid pMT504 previously digested with EcoRI and EcoRV.
The Ϫ10 to Ϫ6 base substitution template was generated by PCR using pMT513 as the template and rRNA-4 and Tx28 as the primers. The PCR product was phosphorylated, digested with EcoRI, and ligated to plasmid pMT504 previously digested with EcoRI and EcoRV.
In vitro transcription. 32 P-labeled RNA was synthesized in a 30-l reaction mixture containing 1 to 3 l of heparin-agarose-purified C. trachomatis RNAP, 10 nM DNA template, 1 mM potassium acetate, 8.1 mM magnesium acetate, 50 mM Tris acetate (pH 8.0), 27 mM ammonium acetate, 1 mM DTT, 3.5% (vol/vol) polyethylene glycol (average molecular weight, 8,000; Sigma), 330
32 P]CTP (3,000 Ci/mmol), 100 mM 3Ј-O-methyl-GTP, Na salt (Pharmacia Biotech, Piscataway, N.J.), and 36 U of RNasin. In some transcription reactions, 0.003 U of E. coli RNAP (Epicentre Technologies, Madison, Wis.) was used instead of C. trachomatis RNAP and the concentration of potassium acetate used was increased from 1 mM to 100 mM. Other reaction conditions were unchanged. Transcription reaction mixtures were incubated at 37ЊC for 35 min and terminated by the addition of 70 l of 2.86 M ammonium acetate containing 4 g of glycogen (Boehringer Mannheim Biochemicals).
32 P-labeled RNA was recovered by ethanol precipitation of the transcription mix and resuspended in 9 l of sequencing stop solution (95% formamide, 20 mM EDTA, 0.05% bromophenol blue, 0.05% xylene cyanol). Three microliters of the sample was electrophoresed on an 8 M urea-6% polyacrylamide gel. Transcripts were visualized by autoradiography and quantified with a Molecular Dynamics (Sunnyvale, Calif.) PhosphorImager. The size of the transcript was determined by coelectrophoresis with an M13 sequencing ladder.
Calculation of relative promoter activity. One consequence of using a plasmid containing two promoters is competition between the promoters for RNAP. These conditions would be expected to underestimate the activities of promoters which are weak relative to a strong control promoter. To minimize this effect, the promoter activity of each test promoter was normalized to that of the control promoter by comparing the PhosphorImager intensities of the test and control transcripts according to the following formula: promoter activity ϭ test transcript intensity/(test transcript intensity ϩ control transcript intensity). The relative promoter activity was calculated as a percentage of the promoter activity of the Ϫ305 promoter template; i.e., promoter activity of the Ϫ305 promoter template was defined as 100%. Performing these experiments under conditions of RNAP excess or limiting template was not technically feasible. We do not believe that the competitive nature of the transcription reactions alters the conclusions.
Inhibition of in vitro transcription by rifampin. Rifampin was dissolved in dimethyl sulfoxide at 25 g/ml and diluted to final concentrations of 16, 160, and 1,600 ng/ml. Components of the transcription reactions, except for the DNA template and the nucleoside triphosphates, were preincubated with rifampin for 15 min on ice. The DNA template, pMT504, and the nucleoside triphosphates were then added to each reaction mix, which was incubated at 37ЊC for 35 min. All subsequent steps were carried out as described above.
Primer extension analysis of in vitro transcription products. Unlabeled in vitro transcripts were synthesized from plasmid pMT513 as described above, with the following changes: each 30-l reaction mixture contained 3 l of heparinagarose-purified C. trachomatis RNAP, 330 M CTP, and no [␣-32 P]CTP. RNA from five separate reactions was pooled. In vitro synthesis of RNA by E. coli RNAP was performed in a single 30-l reaction containing 0.1 U of E. coli RNAP. Prior to primer extension analysis, RNA samples were treated with RQ1 DNase to remove the DNA template. Primer extension analysis was carried out as previously described (12), using 32 P-end-labeled primer Tx27, which is complementary to the extreme 3Ј end of the test G-less cassette template. Primer extension products were electrophoresed next to a Tx27-primed DNA sequence of pMT513.
RESULTS AND DISCUSSION
Purification of C. trachomatis RNAP by heparin-agarose column chromatography. C. trachomatis RNAP was partially purified by heparin-agarose column chromatography, a procedure that has been used as a single-column purification method for RNAPs from E. coli, Bacillus subtilis, and several other bacteria (4). Heparin-agarose purification of RNAP is known to remove nucleases and endogenous DNA (4), both of which are present in other C. trachomatis transcription extracts (23, 25) . The heparin-agarose-purified C. trachomatis RNAP prepared in this manner was relatively free of RNase activity (35a). This partially purified RNAP correctly transcribed several C. trachomatis promoter templates, including rRNA P1 (described below) and the groE and dnaK operon promoters (36) . Analysis of the partially purified extract by sodium dodecyl sulfate-polyacrylamide gel electrophoresis followed by silver staining revealed many proteins (data not shown), indicating that the extract was still relatively crude.
C. trachomatis RNAP is transcriptionally active. The transcriptional activity of the heparin-purified extract was assayed by using the putative promoter region of the C. trachomatis rRNA operons. The C. trachomatis genome contains two rRNA operons, each encoding the 16S and 23S rRNA genes (12) . The 380-bp upstream regions preceding the start of the 16 nucleotides (8, 12) . Alternatively, an extended Ϫ10 promoter sequence (TGn-TATAAG) with fiveof-six match to the canonical E. coli 70 promoter sequence can be found, albeit three nucleotides closer to the apparent in vivo transcription initiation site.
To test if these putative promoters are active in vitro, the region of the 16S rRNA gene that contains P1 and P2 (extending from positions Ϫ305 to ϩ239 relative to P1) was cloned into a T7 terminator plasmid (Fig. 1) . In vitro transcription of this template using the heparin-agarose-purified C. trachomatis RNAP produced a 305-nucleotide transcript (data not shown), corresponding to a transcript initiating at P1 (and extending for 239 nucleotides of rRNA sequence and 66 nucleotides of plasmid sequence that precede the T7 terminator). Initiation at P2 would produce a transcript of 203 to 205 nucleotides in length; no such transcript was observed (data not shown).
For all subsequent analyses, a G-less cassette plasmid was used. The G-less cassette is a synthetic transcription template that does not encode any guanosine residues. Thus, in the absence of added GTP and in the presence of the chain terminator 3Ј-O-methyl-GTP (33), only transcripts that do not contain guanosine residues can accumulate. The only promoters that can be transcribed are those positioned immediately upstream of or within the G-less cassette; adventitious transcription and read-through transcription originating upstream of the promoter being tested are greatly reduced. RNAP pauses at the end of the G-less cassette where there are three encoded guanosine residues; thus, only single-round transcription occurs. Use of the G-less cassette template improved the transcription signal and virtually eliminated background transcripts, greatly increasing the sensitivity of the in vitro transcription system.
The heparin-agarose-purified C. trachomatis RNAP was used to transcribe the C. trachomatis rRNA P1 region (Ϫ305 to ϩ5) cloned into the test promoter region of the double G-less cassette plasmid (Fig. 1 ). An example of this transcription using plasmid pMT513 ( Fig. 1 and Materials and Methods) is shown ( Fig. 2A, lane 1) . Two transcription products, corresponding to the test and control transcripts, were produced. No other plasmid-specific transcripts were observed. No transcription was observed from the rRNA P2 region cloned into a G-less cassette plasmid (data not shown).
The precise start site of the rRNA P1-dependent G-less cassette transcript was verified by primer extension analysis. Figure 3 demonstrates that the in vitro transcript mapped to the most 5Ј of the three adjacent RNA ends mapped in vivo (12) . It should be noted that in the construction of the G-less cassette plasmid, the second of the three in vivo transcription initiation sites was changed from a guanosine residue to an adenosine, so that transcription could be performed in the absence of GTP. The effect of this substitution on the selection of the transcription initiation site is unknown.
Optimal transcription conditions. Transcription of linearized or nicked DNA templates was decreased compared to that of supercoiled DNA templates (35a) . A 75% decrease in transcription was observed with a linearized DNA template. Transcription was not affected by Mg 2ϩ concentration in the range of 8 to 14 mM. Optimal transcription was observed at a concentration of 1 to 10 mM Na ϩ or K ϩ . Transcriptional activity of some, but not all, C. trachomatis RNAP preparations was inhibited at higher Na ϩ or K ϩ concentrations. This inhibition appeared to correlate with the presence of an endonuclease activity in the RNAP preparations. An endonuclease activity has been found in RNAP prepared by the high-salt extract method (25) . Optimal transcription at lower ionic concentrations is likely explained by the observation that the endonuclease activity is significantly reduced at low ionic strength (35a).
Transcription was equally efficient at 30, 37, and 42ЊC. Transcription levels at 37ЊC increased linearly with time up to 30 
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on March 1, 2013 by PENN STATE UNIV http://jb.asm.org/ min, after which they remained at a constant level for up to 60 min. Longer incubation times were not tested. The RNAP activity is derived from C. trachomatis. Two criteria were used to demonstrate that the RNAP activity was derived from C. trachomatis and not from host eukaryotic cells or from contaminating organisms such as Mycoplasma spp. First, a heparin-agarose-purified extract prepared from uninfected HeLa cells showed no transcriptional activity from rRNA P1 (data not shown). Second, the C. trachomatis RNAP extract was shown to be inhibited by rifampin at concentrations similar to those which inhibit E. coli RNAP (data not shown). This rifampin sensitivity argues against contaminating Mycoplasma RNAP activity, as Mycoplasma spp. are unique among eubacteria in exhibiting 100-fold greater resistance to rifampin (17) . We thus conclude that the transcriptional activity of our RNAP extract is derived from C. trachomatis.
5-deletional analysis of the C. trachomatis rRNA P1 promoter: apparent absence of an UP element. To further delineate the 5Ј extent of DNA sequences sufficient for rRNA P1 promoter activity, a series of mutant templates containing nested 5Ј deletions of the Ϫ305-bp rRNA P1 upstream region was constructed. An internal control promoter was included on each plasmid to account for variations in the amounts of supercoiled plasmid and RNAP used. Preliminary experiments using the G-less cassette plasmid demonstrated that sequences from positions Ϫ53 to ϩ5 relative to the transcription initiation site (referred to as the Ϫ53 deletion template) produced a level of transcription similar to that of sequences from Ϫ305 to ϩ5 (the Ϫ305 deletion template) as quantified with a PhosphorImager ( Fig. 2A; compare lanes 1 and 2) . Based on these results, the Ϫ53 deletion template was used as the promoter region for the control G-less cassette (illustrated by pMT513 [ Fig. 1 and Materials and Methods]). In vitro transcription of a plasmid containing both a test promoter and the internal control promoter produced two transcripts, a larger test transcript and a shorter control transcript, from which the relative promoter activity of each test promoter template was determined (see Materials and Methods). Figure 2A shows the results of transcription experiments using 5Ј deletions of rRNA P1 (described in Table 1 ). The relative promoter activities of the 5Ј-deletion templates are shown in Fig. 2C . Compared to the Ϫ305 deletion template, the Ϫ53 deletion showed a modest decrease in the level of transcription (89%, with the level of Ϫ305 deletion normalized to 100%). Levels of transcription of the Ϫ53, Ϫ42, and Ϫ40 deletions were similar to each other, but there was a large decrease in transcription with the Ϫ37, Ϫ33, and Ϫ30 deletion templates. Deletion beyond Ϫ27 abolished all transcriptional activity (data not shown). Thus, the 5Ј extent of the rRNA P1 promoter is likely to be located between positions Ϫ37 and Ϫ40. The minimal effect on promoter activity seen with deletion of sequences upstream of Ϫ40 of C. trachomatis rRNA P1 is in marked contrast to the 30-fold decrease in promoter activity seen when the UP element of E. coli rrnB P1 (located within Ϫ60 to Ϫ40 [Fig. 4 ]) is deleted (30) . These results suggest that C. trachomatis rRNA P1 does not contain a stimulatory element upstream of position Ϫ40.
E. coli RNAP does not require sequences upstream of position ؊40 for transcription from C. trachomatis rRNA P1. In vitro transcription with E. coli RNAP also produced a single prominent transcript from the Ϫ305 deletion template (Fig.  2B, lane 1) . Primer extension analysis showed that the in vitro transcription initiation sites for C. trachomatis and E. coli RNAPs are identical (Fig. 3 ). As seen with C. trachomatis RNAP, a similar dramatic decrease in promoter activity between the Ϫ40 and Ϫ37 promoter templates was also seen for E. coli RNAP (Fig. 2B and C) . This finding suggests that the two RNAPs recognize a 5Ј promoter boundary that is in approximately the same location. Of note, the residual promoter activity of the Ϫ37, Ϫ33, and Ϫ30 deletions was greater with C. trachomatis RNAP than with E. coli RNAP. Since deletion of sequences upstream of Ϫ40 had no effect on transcription by E. coli RNAP, it is apparent that E. coli RNAP does not recognize any UP element upstream of Ϫ40 as part of C. trachomatis rRNA P1. The UP element is thought to be involved in the elevated expression of particular genes involved in rapid growth. The absence of an UP element in relatively slowly growing chlamydiae would not be inconsistent with this hypothesis. In addition, sequences from Ϫ60 to Ϫ40 of C. trachomatis rRNA P1 do not resemble the sequence of the UP element in E. coli (30) or B. subtilis (16, 20) .
Deletional analysis of rRNA P1 near the transcription initiation site. The contribution to promoter activity of DNA sequences immediately upstream of the rRNA P1 initiation site was tested with a series of deletion templates (Table 1) . Transcription with C. trachomatis RNAP showed significant differences between the wild-type and deletion templates (Fig.   FIG. 3 . Primer extension analysis of in vitro transcription products of rRNA P1. Primer Tx27 (complementary to the extreme 3Ј-end of the test G-less cassette template) was used to map the in vitro transcription initiation site of rRNA P1 cloned upstream of the test G-less cassette template in pMT513. Primer extension products for transcripts produced by E. coli RNAP (lane 1) and C. trachomatis RNAP (lane 2) were electrophoresed next to a Tx27-primed DNA sequence of pMT513 (marked GATC). The site of in vitro transcription initiation is the same for both E. coli and C. trachomatis RNAPs and is marked with an arrow.
FIG. 4.
Comparison of the sequences upstream of selected rRNA operons of C. trachomatis and E. coli. Sequences of C. trachomatis rRNA P1 and E. coli rrnB P1 are aligned at their respective transcription initiation sites (indicated by asterisks). The location of the E. coli rrnB P1 Ϫ35 and Ϫ10 promoter elements are underlined, and the location of the UP element is indicated. For comparison, the proposed E. coli canonical 70 promoter sequence (29) is also shown. The direct repeat sequence in the C. trachomatis rRNA P1 region is delineated by two arrows. VOL. 178, 1996 IN VITRO ANALYSIS OF C. TRACHOMATIS rRNA P1 PROMOTER 6979 5A; summarized in Fig. 5C ). The ⌬3 deletion template (deletion of sequences from Ϫ3 to Ϫ1) produced a single test transcript shorter by four nucleotides (lane 2). Transcription of the ⌬5 and ⌬6 deletion templates was complex, but in general the approximate transcription initiation position was maintained relative to the upstream promoter sequences. However, the nucleotide sequence in the region of transcription initiation was not preserved in the ⌬5 and ⌬6 constructs; we speculate that this accounts for the imprecise initiation sites. The ⌬5 deletion template (deletion of Ϫ5 to Ϫ1) produced smaller quantities of two transcripts (lane 3) that were four and six nucleotides shorter than that produced from the Ϫ53 template. The ⌬6 deletion template (deletion of Ϫ6 to Ϫ1) produced four prominent test transcripts (lane 4) that were six, seven, eight, and nine nucleotides shorter than the Ϫ53 template transcript. The total amount of transcription observed with the ⌬6 deletion template were consistently higher than for the Ϫ53 template.
A sharp decrease in promoter activity was seen for the ⌬7 (lane 5) and ⌬9 (data not shown) deletion templates compared to the ⌬6 template (lane 4). These results suggest that sequences upstream of Ϫ6 are required for promoter activity. An alternative explanation that cannot be ruled out is that the failure to see transcription from the ⌬7 and ⌬9 deletion templates is due to an unfavorable nucleotide sequence in the region of transcription initiation in these mutant templates.
This deletional analysis was repeated with E. coli RNAP ( Fig. 5B and C) , and a dramatic decrease in promoter activity between the ⌬6 and ⌬7 deletion templates was again seen. The ⌬5 and ⌬6 deletion templates showed increased transcription levels and a pattern of altered transcript size different from that seen with C. trachomatis RNAP. We hypothesize that this result reflects differences in RNAP preference for the initiating nucleotide.
C. trachomatis RNAP appears to have a sequence preference for an adenosine or thymidine residue at the site of transcription initiation. The efficiency of transcription initiation from a guanosine residue could not be tested because transcription from the G-less cassette plasmids was carried out in the absence of GTP.
An important caveat to the deletion experiments is that adjacent plasmid sequences may have an effect on promoter activity. That is, it remains possible that one or more of the deletion constructs contain fortuitous promoter sequences comprised of plasmid sequences alone or in combination with native rRNA sequences. Thus, our delineation of the promoter region by deletion analysis to the region Ϫ37 to Ϫ6 is approximate.
Multiple base substitution analysis of rRNA P1. Using the results of the deletional analyses as an approximate guide, we performed a base substitution analysis of the 50-bp region upstream of rRNA P1. This analysis eliminates the potential effect of adjacent plasmid sequences. A series of mutant templates, each containing a substitution of five consecutive base pairs, was constructed in pMT513 (Materials and Methods). A wild-type purine was replaced by the noncomplementary pyrimidine, and a wild-type pyrimidine was replaced by the noncomplementary purine. All other sequences, including flanking sequences from the C. trachomatis rRNA P1 upstream region (Ϫ305 to ϩ5) and plasmid sequences, were identical.
Nine nonoverlapping 5-bp substitution mutants were constructed to scan the region between Ϫ50 and Ϫ6 relative to rRNA P1 (Table 1) . The amounts of test transcript observed for promoter templates containing 5-bp substitutions of Ϫ40 to Ϫ36, Ϫ35 to Ϫ31, Ϫ30 to Ϫ26, and Ϫ25 to Ϫ21 were significantly decreased relative to amounts of the control transcripts ( Fig. 6A and C) . The amounts of test transcript were also significantly decreased with 5 bp substitutions of Ϫ15 to Ϫ11 and Ϫ10 to Ϫ6. The intervening substitution (Ϫ20 to Ϫ16) showed wild-type promoter activity, suggesting that this 5-bp substitution had no effect on promoter activity. Thus, these mutations define two subregions of the promoter.
This general structure of two separated promoter elements is analogous to that of many eubacterial promoters, including the E. coli 70 promoter. In the latter case, the two promoter elements have been shown to be points of contact with two distinct regions of the subunit of RNAP (5). The upstream element of C. trachomatis rRNA P1 appears to be more extended than its 70 equivalent. Our results place this upstream element in the approximate region Ϫ40 to Ϫ21, but this is an estimate based on the low-level resolution of the 5-bp substitution analysis. Similarly, the downstream element is located within the approximate region Ϫ15 to Ϫ6.
E. coli RNAP does not recognize the extended portion of the C. trachomatis rRNA P1 upstream promoter element. When the same rRNA P1 base substitution templates were transcribed with E. coli RNAP, some similarities as well as an important difference were noted ( Fig. 6B and C) . Five-basepair substitutions of Ϫ40 to Ϫ36, Ϫ35 to Ϫ31, Ϫ15 to Ϫ11, and Ϫ10 to Ϫ6 decreased transcription by E. coli RNAP. These two regions correspond to the well-described Ϫ35 and Ϫ10 70 promoter elements, respectively. The promoter activity of substitutions from Ϫ30 to Ϫ26 and Ϫ25 to Ϫ21 was not significantly decreased in the reactions using E. coli RNAP. This is in sharp distinction to the results seen with C. trachomatis RNAP. The contrast is most striking for substitutions of Ϫ25 to Ϫ21, which exhibited a modestly increased promoter activity with E. coli RNAP but almost no promoter activity with C. trachomatis RNAP.
Inspection of the nucleotide sequence of the upstream region reveals the presence of a 12-bp direct repeat spanning the approximate upstream region delineated by the base substitution analysis. The sequence AGAAAAAATAGA occurs from Ϫ43 to Ϫ32 and again from Ϫ28 to Ϫ17 (Fig. 4 and 6C) . Interestingly, the 5-bp CCCCC substitution for the wild-type AAAAA sequences, at Ϫ40 to Ϫ36 and Ϫ25 to Ϫ21, is in the middle of each 12-bp repeat and produced significant decreases in promoter activity at both locations. The effect of the substitution at Ϫ25 to Ϫ21 is intriguing because the most striking difference in promoter specificity between C. trachomatis RNAP and E. coli RNAP was seen at this position. To further characterize rRNA P1 and to explore the possible role of the direct repeat sequence, we are currently performing a comprehensive point substitution analysis of the two promoter elements that we have identified. It is possible that the direct repeat represents a DNA binding site for RNAP or other proteins involved in transcription. It is also possible that the high AT content of the direct repeat sequence results in bending of the DNA in this region. The direct repeat sequence bears some resemblance to the E. coli UP element (Fig. 4) .
These results suggest that the promoter structure of C. trachomatis rRNA P1 may differ from the canonical E. coli 70 promoter structure. C. trachomatis and E. coli RNAP also appear to show differences in promoter specificity. However, we note that the C. trachomatis RNAP preparation used was not purified to homogeneity. Thus, it is possible that the differences in promoter specificity are due to other C. trachomatis proteins present in the extract and thus do not represent an intrinsic feature of the C. trachomatis RNAP. It has been reported that no differences can be detected in quantitative transcription assays when highly purified E. coli holoenzyme is compared with E. coli RNAP purified by the single-step heparin-agarose method (4) .
The in vitro transcription system that we have developed to study intrinsic promoter activity is also suitable for studying the regulation of transcription in C. trachomatis. cis-acting regulatory elements that modify promoter activity can be identified if the necessary transcription factors are also present. Transcription factors may be found in the heparin-agarose-purified RNAP preparation, or they can be added separately in cell extract or purified form. Such an assay system can facilitate the subsequent purification of C. trachomatis transcription factors. VOL. 178, 1996 IN VITRO ANALYSIS OF C. TRACHOMATIS rRNA P1 PROMOTER 6981
